Literature DB >> 22829323

Percutaneous image-guided implantation of totally implantable venous access ports in the forearm or the chest? A patients' point of view.

Jan Peter Goltz1, Bernhard Petritsch, Johannes Kirchner, Dietbert Hahn, Ralph Kickuth.   

Abstract

PURPOSE: This study aimed to compare patients' satisfaction and impact on daily life after implantation of totally implantable venous access ports (TIVAP) in the forearm and the chest.
METHODS: In this prospective study, 50 patients (mean age, 55.8 ± 15.4 years) received three questionnaires on days 1, 30, and 90 after implantation in the forearm (n = 25) or the chest (n = 25). Knowledge concerning device function, comfort perception, and impact of TIVAP on daily activities were evaluated. Ratings were dichotomized depending on whether statements were agreed with or contradicted. Fisher's exact test was used to determine differences between the forearm port (FP) and chest port (CP) groups.
RESULTS: There was no significant difference between the two groups with regard to unpleasant feelings (p = 0.09) and discomfort while puncturing (p = 0.06). Main fears in both groups were dysfunction and infection. The possibility of high-pressure injections via the TIVAP was rated important in both groups. More CP patients feared dislocation of their TIVAP during sleep (p < 0.05). CP patients experienced more negative perceptions while driving a car and wearing brassieres (p < 0.05) than FP patients. All patients would recommend their device.
CONCLUSIONS: During certain activities, the FP device seems to be favorable, since it causes less discomfort than the CP.

Entities:  

Mesh:

Year:  2012        PMID: 22829323     DOI: 10.1007/s00520-012-1544-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  16 in total

1.  Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients.

Authors:  H Lorch; M Zwaan; C Kagel; H D Weiss
Journal:  Cardiovasc Intervent Radiol       Date:  2001 May-Jun       Impact factor: 2.740

2.  Peripherally placed totally implantable venous-access port systems of the forearm: clinical experience in 763 consecutive patients.

Authors:  Jan P Goltz; Anne Scholl; Christian O Ritter; Günther Wittenberg; Dietbert Hahn; Ralph Kickuth
Journal:  Cardiovasc Intervent Radiol       Date:  2010-04-23       Impact factor: 2.740

3.  Ultrasound-Guided Radiological Placement of Central Venous Port via the Subclavian Vein: A Retrospective Analysis of 500 Cases at a Single Institute.

Authors:  Notiaki Sakamoto; Yasuaki Arai; Yoshito Takeuchi; Mahahide Takahashi; Masakatsu Tsurusaki; Kazuro Sugimuta
Journal:  Cardiovasc Intervent Radiol       Date:  2010-10       Impact factor: 2.740

4.  Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems.

Authors:  Ulf K M Teichgräber; Stephan Kausche; Sebastian N Nagel; Bernhard Gebauer
Journal:  Eur Radiol       Date:  2011-01-05       Impact factor: 5.315

5.  [Radiological placement of peripheral central venous access ports at the forearm. Technical results and long term outcome in 391 patients].

Authors:  M Lenhart; S Schätzler; C Manke; M Strotzer; J Seitz; J Gmeinwieser; M Völk; N Zorger; S Feuerbach; T Herold; C Paetzel
Journal:  Rofo       Date:  2009-06-17

6.  Satisfaction and quality of life: a survey-based assessment in patients with a totally implantable venous port system.

Authors:  S N Nagel; U K M Teichgräber; S Kausche; A Lehmann
Journal:  Eur J Cancer Care (Engl)       Date:  2011-08-18       Impact factor: 2.520

7.  Jugular versus subclavian totally implantable access ports: catheter position, complications and intrainterventional pain perception.

Authors:  Cédric Plumhans; Andreas H Mahnken; Christina Ocklenburg; Sebastian Keil; Florian F Behrendt; Rolf W Günther; Felix Schoth
Journal:  Eur J Radiol       Date:  2010-03-12       Impact factor: 3.528

8.  Identification of risk factors for catheter-related thrombosis in patients with totally implantable venous access ports in the forearm.

Authors:  Jan P Goltz; Jan S Schmid; Christian O Ritter; Pascal Knödler; Bernhard Petritsch; Johannes Kirchner; Dietbert Hahn; Ralph Kickuth
Journal:  J Vasc Access       Date:  2012 Jan-Mar       Impact factor: 2.283

9.  A comparison between distal and proximal port device insertion in head and neck cancer.

Authors:  P-Y Marcy; E Chamorey; N Amoretti; K Benezery; R J Bensadoun; A Bozec; G Poissonnet; O Dassonville; M Rame; A Italiano; F Peyrade; F Brenac; J C Gallard
Journal:  Eur J Surg Oncol       Date:  2007-11-05       Impact factor: 4.424

10.  Patients' perceptions of having a central venous catheter or a totally implantable subcutaneous port system-results from a randomised study in acute leukaemia.

Authors:  Eva Johansson; Per Engervall; Hjördis Björvell; Robert Hast; Magnus Björkholm
Journal:  Support Care Cancer       Date:  2008-05-01       Impact factor: 3.603

View more
  13 in total

1.  Short-term and long-term outcome of radiological-guided insertion of central venous access port devices implanted at the forearm: a retrospective monocenter analysis in 1704 patients.

Authors:  Moritz Wildgruber; Sebastian Borgmeyer; Bernhard Haller; Heike Jansen; Jochen Gaa; Marion Kiechle; Reinhard Meier; Johannes Ettl; Hermann Berger
Journal:  Eur Radiol       Date:  2014-09-20       Impact factor: 5.315

2.  Insertion of totally implantable central venous access devices by surgeons.

Authors:  Hyeonjun An; Chun-Geun Ryu; Eun-Joo Jung; Hyun Jong Kang; Jin Hee Paik; Jung-Hyun Yang; Dae-Yong Hwang
Journal:  Ann Coloproctol       Date:  2015-04-30

Review 3.  Adult oncology patients' experiences of living with a central venous catheter: a systematic review and meta-synthesis.

Authors:  Dhurata Ivziku; Raffaella Gualandi; Francesca Pesce; Anna De Benedictis; Daniela Tartaglini
Journal:  Support Care Cancer       Date:  2022-01-14       Impact factor: 3.603

4.  Brachial insertion of fully implantable venous catheters for chemotherapy: complications and quality of life assessment in 35 patients.

Authors:  Igor Yoshio Imagawa Fonseca; Mariana Krutman; Kenji Nishinari; Guilherme Yazbek; Marcelo Passos Teivelis; Guilherme André Zottele Bomfim; Rafael Noronha Cavalcante; Nelson Wolosker
Journal:  Einstein (Sao Paulo)       Date:  2016 Oct-Dec

5.  Living with a peripherally inserted central catheter: the perspective of cancer outpatients-a qualitative study.

Authors:  Paula Parás-Bravo; María Paz-Zulueta; Miguel Santibañez; Cesar Fernández-de-Las-Peñas; Manuel Herrero-Montes; Vanesa Caso-Álvarez; Domingo Palacios-Ceña
Journal:  Support Care Cancer       Date:  2017-07-13       Impact factor: 3.603

6.  Arm port vs chest port: a systematic review and meta-analysis.

Authors:  Guanhua Li; Yu Zhang; Hongmin Ma; Junmeng Zheng
Journal:  Cancer Manag Res       Date:  2019-07-03       Impact factor: 3.989

7.  Late complications of totally implantable venous access ports in patients with cancer: Risk factors and related nursing strategies.

Authors:  Xin-Yan Yu; Jia-Lan Xu; Dan Li; Zi-Fang Jiang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

8.  Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative study.

Authors:  Caoimhe Ryan; Hannah Hesselgreaves; Olivia Wu; Jonathan Moss; James Paul; Judith Dixon-Hughes; Evi Germeni
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

9.  PICC-PORT: Valid indication to placement in patient with results of extensive skin burns of the neck and chest in oncology. The first case in the scientific literature.

Authors:  D Merlicco; M Lombardi; M C Fino
Journal:  Int J Surg Case Rep       Date:  2020-02-19

10.  Application and comparison of different implanted ports in malignant tumor patients.

Authors:  Yanhong Li; Yonghua Cai; Xiaoqin Gan; Xinmei Ye; Jiayu Ling; Liang Kang; Junwen Ye; Xingwei Zhang; Jianwei Zhang; Yue Cai; Huabin Hu; Meijin Huang; Yanhong Deng
Journal:  World J Surg Oncol       Date:  2016-09-23       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.